Literature DB >> 23470140

Trends in the surgical management of localized renal masses: thermal ablation, partial and radical nephrectomy in the USA, 1998-2008.

Jeffrey M Woldrich1, Kerrin Palazzi, Sean P Stroup, Roger L Sur, J Kellogg Parsons, David Chang, Ithaar H Derweesh.   

Abstract

OBJECTIVE: To evaluate the diffusion of nephron-sparing modalities (NSM) for the treatment of renal neoplasms in the USA over the last decade and to identify the factors associated with renal procedure selection. PATIENTS AND METHODS: The Nationwide Inpatient Sample was utlized to identify patients undergoing cryo/radiofrequency ablation (C/RFA), radical nephrectomy (RN) and partial nephrectomy (PN) from 1998 to 2008. Annual trends in procedure prevalence were determined. Multivariate analyses were performed to query the influence of age, race, sex and comorbid disease on surgery selection.
RESULTS: We identified 443,853 procedures performed during the study period: 25,599 C/RFA, 79,568 PN and 338,687 RN. The prevalence per 100,000 hospital admissions in 1998 was 3.7 for C/RFA, nine for PN and 87.1 for RN. All procedures increased over the study period, by 1.05, 3.1 and 2.2/100,000 admissions per year, respectively (all P < 0.001). Diabetes, urban, teaching and large capacity hospitals were associated with NSM (either C/RFA or PN) compared to RN (all P ≤ 0.011). Age ≥70 years, female, hypertension, diabetes, chronic kidney disease (CKD) and region outside the Northeast favoured C/RFA over PN (all P ≤ 0.026). Compared to those without CKD, patients with CKD had an almost twofold higher probability of undergoing RN than NSM (odds ratio, 1.88; 95% confidence interval, 1.7-2.1). Despite increasing NSM utilization over the study period, most patients with CKD still received RN.
CONCLUSIONS: Although the prevalence of NSM is increasing, RN is more common. The low utilization of NSM in patients with pre-existing CKD warrants further investigation.
© 2013 BJU International.

Entities:  

Mesh:

Year:  2013        PMID: 23470140     DOI: 10.1111/j.1464-410X.2012.11497.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  23 in total

1.  Robot-assisted versus laparoscopic partial nephrectomy for localized renal tumors: a meta-analysis.

Authors:  Xiaolong Zhang; Jiajun Yan; Yu Ren; Chong Shen; Xiangrong Ying; Shouhua Pan
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Small renal masses: Troubling nephrectomy trend data.

Authors:  Sarah Payton
Journal:  Nat Rev Urol       Date:  2013-03-26       Impact factor: 14.432

Review 3.  Renal Function Following Nephron Sparing Procedures: Simply a Matter of Volume?

Authors:  Michael J Biles; G Joel DeCastro; Solomon L Woldu
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

Review 4.  Renal ablation update.

Authors:  Vishal Khiatani; Robert G Dixon
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

5.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 6.  Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes.

Authors:  Nicholas Kavoussi; Noah Canvasser; Jeffrey Caddedu
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

7.  Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation.

Authors:  Alp Tuna Beksac; Gerant Rivera-Sanfeliz; Catherine A Dufour; Unwanaobong Nseyo; Zachary Hamilton; Sean W Berquist; Abd-elRahman Hassan; Omer A Raheem; Song Wang; Robert W Wake; Robert E Gold; Ithaar H Derweesh
Journal:  World J Urol       Date:  2016-08-02       Impact factor: 4.226

Review 8.  Post partial nephrectomy surveillance imaging: an evidence-based approach.

Authors:  Lorenzo Marconi; Michael A Gorin; Mohamad E Allaf
Journal:  Curr Urol Rep       Date:  2015-04       Impact factor: 3.092

Review 9.  Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.

Authors:  Serge Ginzburg; Jeffrey J Tomaszewski; Alexander Kutikov
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

Review 10.  Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.

Authors:  Frank Kunath; Stefanie Schmidt; Laura-Maria Krabbe; Arkadiusz Miernik; Philipp Dahm; Anne Cleves; Mario Walther; Nils Kroeger
Journal:  Cochrane Database Syst Rev       Date:  2017-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.